Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in Combination with Chemotherapy for Treatment of Metastatic Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the United States First published 08/02/2023 Last updated 08/02/2023 EU PAS number:EUPAS41157 Study Finalised